I'm back from a 2 month holiday in Europe and on the hunt for more evidence.
Looks like we already have surgeons taking it upon themselves to integrate BTM into abdominal wall reconstruction. This is fantastic.
Two-Layer Biodegradable Temporizing Matrix Reconstruction of Abdominal Wall Dermatofibrosarcoma Protuberans (Shah et. al, 2022)
https://academic.oup.com/bjs/article/109/Supplement_6/znac269.149/6671959?login=false
Dermatofibrosarcoma protuberans (DFSP) is a rare, locally invasive dermal sarcoma. The management is generally surgical, with wide local excision (WLE) forming the mainstay of treatment. Large abdominal wall defects are most aesthetically reconstructed using pedicled or free flaps; however, these require tumour-free surgical margins, and can cause donor site morbidity. We describe an alternative, aesthetic, and low-morbidity technique for abdominal wall reconstruction following WLE of DFSP, using 2 layers of a novel synthetic dermal matrix (NovoSorb® BTM).
25-year-old women presented with a large DFSP involving the right anterior-abdominal wall. After WLE with 3cm margins, BTM was implanted to the large sub-fascial abdominal wall defect. At 6 weeks, after histological confirmation of tumour-free margins, a second layer of BTM was applied to improve the significant contour deformity of the wound bed. After complete integration by 7 weeks, a split-thickness skin graft was harvested from the right thigh and fixed to the new dermis.
At 14-days postoperatively, the skin graft had fully taken, and donor site healed. By 8 weeks, the scar had started to mature with no obvious contour defect or contracture. Overall, the patient was satisfied with the functional and aesthetic outcome.
To our knowledge, a two-layer reconstruction using an artificial dermal matrix has never been described for abdominal wall reconstruction. We found that double-layer BTM is able to restore the inherent thickness and pliability of skin in complex abdominal wall reconstruction following WLE of DFSP and offers improved durability and cosmesis compared to skin grafting or indeed single layer skin substitutes alone.
- Forums
- ASX - By Stock
- PNV
- The Clinicians Speak
The Clinicians Speak, page-312
-
- There are more pages in this discussion • 728 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.61 |
Change
0.060(2.35%) |
Mkt cap ! $1.801B |
Open | High | Low | Value | Volume |
$2.53 | $2.61 | $2.46 | $2.873M | 1.124M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1310 | $2.60 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.62 | 45784 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1310 | 2.600 |
2 | 1686 | 2.590 |
1 | 1611 | 2.580 |
3 | 9011 | 2.570 |
3 | 9011 | 2.560 |
Price($) | Vol. | No. |
---|---|---|
2.620 | 45784 | 5 |
2.630 | 32075 | 8 |
2.640 | 12055 | 3 |
2.650 | 55782 | 10 |
2.660 | 118292 | 6 |
Last trade - 16.10pm 21/08/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |